Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Radcliffe Department of Medicine and OCDEM are pleased to announce the appointment of Jeremy Tomlinson as the new Professor of Diabetic Medicine.

© Jim Leek

Jeremy was previously  based at the University of Birmingham. He graduated from the University of Oxford Medical School in 1995, having previously completed his undergraduate degree at the University of Cambridge. His research interests combine the action of steroid hormones alongside understanding the mechanism that contribute to obesity, insulin resistance and type 2 diabetes running a truly translational research program.  Professor Steve Gough Chairman of OCDEM said that “Jeremy has an international reputation in steroid metabolism and with interests spanning diabetes, endocrinology and metabolism will strengthen and further develop existing research and clinical activities in OCDEM”

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Spin-out company Alethiomics launches

The enterprise will focus on developing targeted therapies for a specific family of blood cancers.

Iron integral to the development of life on Earth – and the possibility of life on other planets

A collaboration between researchers at the MRC WIMM/RDM and Department of Earth Sciences uncovers the importance of iron for the development of complex life on Earth.

Study reveals ‘stop-eating’ response to DNA damage

A new study from the Patel Group sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.